Lifeward Inc.

Lifeward Inc., a for-profit medical device manufacturer headquartered in Marlborough, Massachusetts, sells robotic exoskeleton systems, functional electrical stimulation (FES) exercise equipment, prosthetic devices, and related rehabilitation technologies to the Department of Veterans Affairs as a prime contractor, competing in full-and-open procurements with no set-aside designation across 101 firm fixed-price purchase orders.

Lifeward operates as the parent entity with a subsidiary, Lifeward CA, Inc. The vendor's capability portfolio centers on MYOCYCLE functional electrical stimulation bicycles, ReWalk robotic exoskeleton systems, prosthetic therapy equipment, electrotherapy systems, and replacement components such as electrodes and battery packs. Representative prime awards include a $132,437.69 purchase order from Veterans Integrated Service Network 21 for M3 corpus conversion (May 2026), a $123,937.67 order from VISN 10 for ReWalk 7 exoskeletal systems (November 2025), and a $101,437.67 award from VISN 8 for exoskeleton equipment (February 2026). The vendor also holds awards for single-unit patient-specific devices—for example, a $27,660 order from VISN 5 for MYOCYCLE V2 Home Plus systems for individual veterans (February 2024) and a $31,000 award from VISN 9 for exoskeleton upgrades (December 2023). All awards are firm fixed-price purchase orders with no parent vehicle or set-aside involvement.

Lifeward's customer footprint is concentrated within the Veterans Health Administration. The top five VISNs account for 59% of award volume: VISN 5 leads with 16 awards totaling $365 thousand, followed by VISN 9 with 15 awards and $414 thousand combined potential value, VISN 16 with 12 awards and $290 thousand, VISN 7 with 10 awards and $194 thousand, and VISN 19 with 7 awards and $179 thousand. Across 17 distinct VA service networks, the vendor delivers rehabilitation and prosthetic equipment. By dollar value, VISN 9, VISN 5, VISN 16, VISN 8, and VISN 21 represent 57% of combined potential value; VISN 8's four orders ($254 thousand) and VISN 21's five orders ($223 thousand) anchor deeper than their award counts suggest.

Work is performed at Lifeward's facility in Marlborough, Massachusetts, with selected performance locations in Pennsylvania (Wilkes-Barre, Nanticoke) for specific orders. The vendor has issued 101 prime awards with combined potential value of $2.7 million, fully obligated across the portfolio. Activity peaked in 2023 with 28 awards; the trajectory has moderated to 26 awards in 2024, 11 in 2025, and 10 in 2026 year-to-date. Three awards carrying $250 thousand in combined potential value complete within the next twenty-four months and face recompete exposure. The vendor's NAICS profile is dominated by Surgical Appliance and Supplies Manufacturing (61 awards) and Surgical and Medical Instrument Manufacturing (30 awards), with 10 awards under Electromedical and Electrotherapeutic Apparatus Manufacturing. All 100 PSC-coded awards fall under Medical and Surgical Instruments, Equipment, and Supplies.

The source describes Lifeward as part of or associated with ReWalk Robotics, Inc.; several awards in the portfolio name ReWalk Robotics as the awardee while referencing Lifeward's Marlborough address and product lines, indicating either a subsidiary relationship or operational overlap not fully clarified in the award text. Lifeward competes exclusively in full-and-open, unrestricted federal procurements and holds no parent contracts, GWACs, BPAs, or IDIQs — each order is a discrete purchase order awarded directly by individual Veterans Integrated Service Networks.